Back to CERS Stock Lookup

Cerus Corp (CERS) – Press Releases

Dec 22, 2014 08:30 AM Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
Dec 18, 2014 07:20 PM FDA Approves INTERCEPT Blood System for Platelets
Dec 16, 2014 05:31 PM FDA Approves INTERCEPT Blood System for Plasma
Nov 21, 2014 08:30 AM FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma
Nov 4, 2014 04:01 PM Cerus Corporation Reports Third Quarter 2014 Results
Oct 29, 2014 08:30 AM Cerus Announces Agreement With Kawasumi Laboratories for the Development of INTERCEPT Platelets Kits in Japan
Oct 23, 2014 08:30 AM American Red Cross to Participate in Cerus' IDE Study to Address Chikungunya and Dengue Blood Safety Risks
Oct 22, 2014 08:30 AM Cerus to Release Third Quarter 2014 Results on November 4, 2014
Oct 20, 2014 08:30 AM Cerus Submits Compassionate Use IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma
Oct 7, 2014 08:30 AM U.S. FDA Accepts IDE Submission by Cerus Making the INTERCEPT Blood System Available to Address Chikungunya and Dengue Blood Safety Risks

Back to CERS Stock Lookup